×

What are you searching for?




Pharmaceuticals

4 Min read

JOHNSON & JOHNSON COVID-19 VACCINE SHOWS STRONG IMMUNE RESPONSE IN EARLY TRIALS

Published On 26 Sep 2020 05:03 PM


SHARE THIS ARTICLE  


Highlights

• The report published on Friday said that the safety profile and immunogenicity after only a single dose are supportive for further clinical development of vaccine named Arey.COV2.S at a dose level of 5x1010 vp, as a potentially protective vaccine against the COVID-19

• The report stated that a single dose of Arey.COV2.S elicited strong humoral responses in the vast majority of vaccine recipients.

....


Tags : COVID-19 vaccine, Johnson & Johnson, vaccine trials, ,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)